Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2015	Jun. 30, 2015
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $29,000 and $28,000, respecitvely	$ 26,400	$ 25,400
Series A Preferred Stock [Member]
Deficit:
Series A Preferred stock, $0.01 par value, 10,000 shares authorized, no shares issued and outstanding
Series C Preferred Stock [Member]
Deficit:
Series A Preferred stock, $0.01 par value, 10,000 shares authorized, no shares issued and outstanding
Cash	$ 178,451	$ 339,286
Promissory note receivable (Note 4)	35,000
Prepaid expenses	$ 12,350	$ 18,503
Subscription receivable (Note 9)		13,125
Deposits and other receivables	$ 7,108	7,108
Total current assets	232,909	378,022
Property and equipment, net (Note 3)	1,829,508	1,977,219
Total assets	2,062,417	2,355,241
Accounts payable and accrued expenses	$ 1,479,267	1,353,168
Notes payable - affiliates, net of discount (Note 5)		472,230
Deferred compensation (Note 6)	$ 1,170,731	839,288
Loan payable (Note 7)	7,754,000	7,754,000
Total current liabilities	10,430,398	10,444,086
Convertible notes payable - affiliates, net of current portion (Note 8)	3,218,648	2,654,708
Total liabilities	$ 13,649,046	$ 13,098,794
Common stock, no par value, 100,000,000 shares authorized, 22,855,964 and 22,089,650 shares issued, respectively; 22,151,655 and 21,385,341 shares outstanding, respectively
Promissory note receivable for shares (Notes 4 and 9)	$ (71,878)
Additional paid-in capital	101,747,327	$ 100,889,127
Accumulated deficit	(113,322,889)	(111,696,060)
Total Bion's stockholders' deficit	(11,647,440)	(10,806,933)
Noncontrolling interest	60,811	63,380
Total deficit	(11,586,629)	(10,743,553)
Total liabilities and deficit	$ 2,062,417	$ 2,355,241